SEKZF yields 660.94% · JNJ yields 2.13%● Live data
📍 SEKZF pulled ahead of the other in Year 1
Combined, SEKZF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SEKZF + JNJ for your $10,000?
ESGold Corp., an exploration stage company, engages in the acquisition, exploration, and evaluation of mineral properties in Canada. The company primarily explores for gold and silver deposits. It primarily holds a 100% interest in the Eagle River project that includes 77 claims or 4,354 contiguous hectares located in the Windfall Lake gold district, Quebec. The company also holds interest in the Montauban project, which comprises 65 mining claims and 1 mining concession covering an area of approximately 1,846 hectares situated in the Montauban and Chavigny townships, Quebec. In addition, it holds an option to acquire 50% interests in the Ottawa River project located in Ontario. The company was formerly known as Secova Metals Corp. and changed its name to ESGold Corp. in July 2022. ESGold Corp. was incorporated in 2004 and is headquartered in Vancouver, Canada.
Full SEKZF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.